Hualan Biological Engineering Inc. (SHE:002007)
16.03
-0.05 (-0.31%)
Mar 28, 2025, 3:04 PM CST
SHE:002007 Revenue
In the year 2024, Hualan Biological Engineering had annual revenue of 4.38B CNY, down -18.02%. Hualan Biological Engineering had revenue of 888.55M in the quarter ending December 31, 2024, a decrease of -37.82%.
Revenue
4.38B
Revenue Growth
-18.02%
P/S Ratio
6.68
Revenue / Employee
1.09M
Employees
4,012
Market Cap
29.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.38B | -962.68M | -18.02% |
Dec 31, 2023 | 5.34B | 824.89M | 18.26% |
Jan 1, 2023 | 4.52B | 80.78M | 1.82% |
Jan 1, 2022 | 4.44B | -587.01M | -11.69% |
Dec 31, 2020 | 5.02B | 1.32B | 35.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Aier Eye Hospital Group | 20.62B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |